Health guidelines recommend that older adults in the US be vaccinated for vaccine-preventable influenza, whooping cough, shingles, and pneumococcal disease. But the number of those choosing to be vaccinated is considered suboptimal.
News Releases
August 17, 2021
When a person donates blood platelets, those platelets become life-saving treatments for a variety of conditions. The amount of blood platelet components (PCs) available at any given time is directly dependent on those donations - but the number of donations is not the only factor that impacts...
August 13, 2021
Most of what we know about treatments, adverse events, and the overall survival of patients with chronic lymphocytic leukemia (CLL) and mantle cell lymphoma (MCL) comes from clinical trials. Confirmatory real-world evidence, especially in the Medicare population, is limited. In existing studies...
July 16, 2021
The ENCePP Guide on Methodological Standards in Pharmacoepidemiology was created and is maintained by members of the European Network of Centres for Pharmacoepidemiology and Pharmacovigilance (ENCePP)–specifically, the ENCePP Working Group 1 on Research Methods and Guidance, chaired by RTI...
New Research Shows Sustained Relationship Between Psoriasis Symptom Improvements and Quality of Life
July 16, 2021
Psoriasis produces symptoms such as skin scaling, itching, and pain; an additional diagnosis of psoriatic arthritis adds to the symptom burden and can permanently damage joints. Research has documented the relationship between psoriasis disease severity and quality of life (QoL) well.
June 16, 2021
What Matters Most to Patients and Caregivers
Dana DiBenedetti, PhD
Executive Director, Patient-Centered Outcomes Assessment
May 28, 2021
While we certainly missed being able to engage in person with everyone at ISPOR, the virtual conference does provide an advantage: on-demand sessions that you can still access until June 30!
As you’re checking out all the on-demand sessions, don't miss the...
May 18, 2021
Major depressive disorder (MDD) is a leading cause of disability worldwide. Understanding the impact of MDD on quality of life has become increasingly key in research.
May 4, 2021
Mutations in breast cancer susceptibility genes are known to increase the risk of inheriting breast cancer. Genetic testing enables persons to determine if they carry that mutation and are at a higher risk of developing cancer. Understanding that risk may help patients make treatment decisions...
April 28, 2021
Adult vaccination rates in the US are generally low and fall short of public health goals. Given the human and economic burden of vaccine-preventable disease, understanding the factors behind these low coverage rates is critical to improving participation.
April 6, 2021
Many patients with Parkinson's disease experience periods during the day of "OFF" episodes, or worsening of symptoms.
March 23, 2021
What do rapidly changing technologies mean to the collection of stated-preference studies – studies that ask individuals what they value in their health and health care?
March 12, 2021
Insights from our experiences developing medical product dossiers, with key considerations for manufacturers planning to develop early dossiers for their products.
February 10, 2021
For the fifth straight year, Forbes has included RTI in its list of America’s Best Midsize Employers
February 1, 2021
MINERVA project (Metadata for data discoverability and study replicability in observational studies) is launched
January 28, 2021
"I am honored to serve on the ENCePP Steering Committee on behalf of research centers in Europe."
January 25, 2021
The US Food and Drug Administration (FDA) is no longer requiring a black box warning on the label for the drug FORTEO® (teriparatide) and has released the drug’s sponsor from its post-market commitments. These moves were based on results from 18 years of epidemiologic research conducted by...
January 22, 2021
Please join Xabier Garcia de Albeniz for this recorded 30-minute case-study workshop on the use of causal inference methods for real-world evidence.
January 15, 2021
Launch of the SIGMA Consortium heralds a new era of collaboration to better understand safety and effectiveness of medical interventions.
January 11, 2021
In 2019, the US Department of Health and Human Services (HHS) announced the “Ending the HIV Epidemic: A Plan for America” initiative. As part of that initiative, CDC, RTI Health Solutions (RTI-HS), and RTI International researchers performed a study on allocating funds for HIV prevention to...
November 20, 2020
HTAi symposium highlights - value assessment in Alzheimer's disease research should incorporate the breadth of relevant outcomes
November 20, 2020
Antibiotics have played a significant role in expanding life expectancy over the last 100 years. However, bacteria have evolved and developed the genetic machinery to adapt and resist antimicrobials, threatening to make antibiotics ineffective – known as antimicrobial resistance (AMR). The...
November 17, 2020
it also explains Markov and Budget Impact Analysis modeling and discusses the advantages and disadvantages of using retrospective databases and real-world data
October 27, 2020
RTI Health Solutions (RTI-HS) is pleased to announce that we are a certified facilitator for the Medtech Early Technical Assessment (META) tool developed by the National Institute for Health and Care Excellence (NICE). META is an online platform designed to provide a budget-friendly value...
October 27, 2020
A first-time study determined that just 30.6% of US 17-year-olds had received all vaccines